Universal Reaction Kit for Sequencing - India CDSCO Medical Device Registration

Universal Reaction Kit for Sequencing is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000481_4e80ae1e6acfc487fbd23ae1762035ba_86d1ccd87e6ef2b3a2f7975748e17909. This device is marketed under the brand name Combinatorial Probe-Anchor Synthesis Sequencing Method. The license holder is Rivaara Labs Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

Universal Reaction Kit for Sequencing

UID: IMP/IVD/2021/000481_4e80ae1e6acfc487fbd23ae1762035ba_86d1ccd87e6ef2b3a2f7975748e17909

Brand Name

Combinatorial Probe-Anchor Synthesis Sequencing Method

License Holder

Rivaara Labs Private Limited

Device Class

Class C

Approving Authority

CDSCO

Product Information

The kit is a set of commonly used reagents for the detection of human genomic DNA library. As a general reagent for the sequencing reaction system, it is used with gene sequencing instrument aiming to obtain sample sequence information through high-throughput sequencing process. This product is not suitable for whole genome sequencing.